Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P ABOULKER

Showing results (111-120 of 134) with videos related to

Pageof 14
Sort By:
AIDS (London, England)|June 1, 1997
A placebo-controlled clinical phase I trial with combined anti-HIV-1 and anti-interferon-alpha immunizationI P Coulaud, M L Gougeon, E Gomard, et al.
Scandinavian Journal of Infectious Diseases|December 1, 2001
Adverse reactions to cotrimoxazole in HIV-infected patients: predictive factors and subsequent HIV disease progressionC Rabaud, I Charreau, S Izard, et al.
Diagnostic Microbiology and Infectious Disease|May 26, 1999
Specific anti-toxoplasmic IgG antibody immunoblot profiles in patients with AIDS-associated Toxoplasma encephalitisF Raffi, J Franck, H Pelloux, et al.
HIV Medicine|September 7, 2013
Lymphoma and Epstein-Barr virus DNA in blood during interleukin-2 therapy in antiretroviral-naïve HIV-1-infected patients: a substudy of the ANRS 119 trialV de Lastours, J LeGoff, J Brière, et al.
The Journal of Antimicrobial Chemotherapy|October 27, 2014
Archived HIV-1 DNA resistance mutations to rilpivirine and etravirine in successfully treated HIV-1-infected individuals pre-exposed to efavirenz or nevirapineS Gallien, I Charreau, M L Nere, et al.
The Journal of Infectious Diseases|September 1, 1995
Lower survival in AIDS patients receiving dapsone compared with aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia. Study GroupD Salmon-Ceron, A Fontbonne, J Saba, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1996
Randomized comparison of amphotericin B deoxycholate dissolved in dextrose or Intralipid for the treatment of AIDS-associated cryptococcal meningitisV Joly, P Aubry, A Ndayiragide, et al.
HIV Medicine|May 24, 2011
Hyperlactataemia in HIV-infected subjects initiating antiretroviral therapy in a large randomized study (a substudy of the INITIO trial)E R Feeney, C Chazallon, N O'Brien, et al.
Clinical and Vaccine Immunology : CVI|June 9, 2006
Evaluation of the interlaboratory concordance in quantification of human immunodeficiency virus-specific T cells with a gamma interferon enzyme-linked immunospot assayA Samri, C Durier, A Urrutia, et al.
Controlled Clinical Trials|June 10, 1998
Intention-to-treat vs. on-treatment analyses of clinical trial data: experience from a study of pyrimethamine in the primary prophylaxis of toxoplasmosis in HIV-infected patients. ANRS 005/ACTG 154 Trial GroupG Chêne, P Morlat, C Leport, et al.
Pageof 14

Showing results (111-120 of 134) with videos related to

Sort By:
Pageof 14
AIDS (London, England)|June 1, 1997
A placebo-controlled clinical phase I trial with combined anti-HIV-1 and anti-interferon-alpha immunizationI P Coulaud, M L Gougeon, E Gomard, et al.
Scandinavian Journal of Infectious Diseases|December 1, 2001
Adverse reactions to cotrimoxazole in HIV-infected patients: predictive factors and subsequent HIV disease progressionC Rabaud, I Charreau, S Izard, et al.
Diagnostic Microbiology and Infectious Disease|May 26, 1999
Specific anti-toxoplasmic IgG antibody immunoblot profiles in patients with AIDS-associated Toxoplasma encephalitisF Raffi, J Franck, H Pelloux, et al.
HIV Medicine|September 7, 2013
Lymphoma and Epstein-Barr virus DNA in blood during interleukin-2 therapy in antiretroviral-naïve HIV-1-infected patients: a substudy of the ANRS 119 trialV de Lastours, J LeGoff, J Brière, et al.
The Journal of Antimicrobial Chemotherapy|October 27, 2014
Archived HIV-1 DNA resistance mutations to rilpivirine and etravirine in successfully treated HIV-1-infected individuals pre-exposed to efavirenz or nevirapineS Gallien, I Charreau, M L Nere, et al.
The Journal of Infectious Diseases|September 1, 1995
Lower survival in AIDS patients receiving dapsone compared with aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia. Study GroupD Salmon-Ceron, A Fontbonne, J Saba, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 1996
Randomized comparison of amphotericin B deoxycholate dissolved in dextrose or Intralipid for the treatment of AIDS-associated cryptococcal meningitisV Joly, P Aubry, A Ndayiragide, et al.
HIV Medicine|May 24, 2011
Hyperlactataemia in HIV-infected subjects initiating antiretroviral therapy in a large randomized study (a substudy of the INITIO trial)E R Feeney, C Chazallon, N O'Brien, et al.
Clinical and Vaccine Immunology : CVI|June 9, 2006
Evaluation of the interlaboratory concordance in quantification of human immunodeficiency virus-specific T cells with a gamma interferon enzyme-linked immunospot assayA Samri, C Durier, A Urrutia, et al.
Controlled Clinical Trials|June 10, 1998
Intention-to-treat vs. on-treatment analyses of clinical trial data: experience from a study of pyrimethamine in the primary prophylaxis of toxoplasmosis in HIV-infected patients. ANRS 005/ACTG 154 Trial GroupG Chêne, P Morlat, C Leport, et al.
Pageof 14